NCT00209313View on ClinicalTrials.gov

Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

April 30, 2007

Conditions
HIV-1 and HSV-2 CoinfectionHIV Infections
Interventions
DRUG

Acyclovir

Acyclovir 800 mg twice daily or placebo

Trial Locations (1)

Unknown

Hospital Central, Yaoundé

All Listed Sponsors
collaborator

Institute for the Development of Africa

UNKNOWN

lead

Fred Hutchinson Cancer Center

OTHER